Ketamine Hydrochloride 25021-0683
Product NDC
25021-0683- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 15, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216809
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ketamine Hydrochloride | 50 mg/mL |
Drug Class
General Anesthesia [PE]General Anesthetic [EPC]
Packaging Options(1)
10 VIAL in 1 CARTON (25021-683-10) / 10 mL in 1 VIAL